Company page

Evelo Biosciences, Inc.

Evelo Biosciences, Inc. is a public company traded under the ticker EVLO in the American market. The company has a market capitalization of approximately $19 billion. Evelo focuses on developing innovative therapies to treat various diseases by leveraging its proprietary platform.

profileEVLO:OTCAI content: aiUpdated June 24, 2026/company/evelo-biosciences-inc/c-nczvsgud
Evelo Biosciences, Inc. logo
Ticker
EVLO:OTC
Asset type
Stock
Market cap
$19
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OTC
Currency
USD